| Management of Kawasaki disease D Eleftheriou, M Levin, D Shingadia, R Tulloh, NJ Klein, PA Brogan Archives of disease in childhood 99 (1), 74-83, 2014 | 378 | 2014 |
| Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease RC Dale, F Brilot, LV Duffy, M Twilt, AT Waldman, S Narula, E Muscal, ... Neurology 83 (2), 142-150, 2014 | 343 | 2014 |
| European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease–the SHARE initiative N de Graeff, N Groot, S Ozen, D Eleftheriou, T Avcin, B Bader-Meunier, ... Rheumatology 58 (4), 672-682, 2019 | 181 | 2019 |
| Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles Y Hong, D Eleftheriou, AAK Hussain, FE Price-Kuehne, CO Savage, ... Journal of the American Society of Nephrology 23 (1), 49-62, 2012 | 175 | 2012 |
| Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases S Nanthapisal, C Murphy, E Omoyinmi, Y Hong, A Standing, S Berg, ... Arthritis & Rheumatology 68 (9), 2314-2322, 2016 | 174 | 2016 |
| Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood D Eleftheriou, T Gerschman, N Sebire, P Woo, CA Pilkington, PA Brogan Rheumatology 49 (8), 1505-1512, 2010 | 161 | 2010 |
| Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS) P Dolezalova, FE Price-Kuehne, S Özen, SM Benseler, DA Cabral, ... Annals of the rheumatic diseases 72 (10), 1628-1633, 2013 | 156 | 2013 |
| Medium-size-vessel vasculitis MJ Dillon, D Eleftheriou, PA Brogan Pediatric Nephrology 25, 1641-1652, 2010 | 145 | 2010 |
| Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1 ASI Standing, D Malinova, Y Hong, J Record, D Moulding, MP Blundell, ... The Journal of experimental medicine 214 (1), 59, 2017 | 138 | 2017 |
| Systemic polyarteritis nodosa in the young: a single‐center experience over thirty‐two years D Eleftheriou, MJ Dillon, K Tullus, SD Marks, CA Pilkington, DJ Roebuck, ... Arthritis & Rheumatism 65 (9), 2476-2485, 2013 | 137 | 2013 |
| Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2) PY Lee, ES Kellner, Y Huang, E Furutani, Z Huang, W Bainter, ... Journal of allergy and clinical immunology 145 (6), 1664-1672. e10, 2020 | 131 | 2020 |
| Biologic therapy in primary systemic vasculitis of the young D Eleftheriou, M Melo, SD Marks, K Tullus, J Sills, G Cleary, P Dolezalova, ... Rheumatology 48 (8), 978-986, 2009 | 130 | 2009 |
| Small vessel vasculitis P Brogan, D Eleftheriou, M Dillon Pediatric Nephrology 25, 1025-1035, 2010 | 116 | 2010 |
| Bayesian methods for the design and interpretation of clinical trials in very rare diseases LV Hampson, J Whitehead, D Eleftheriou, P Brogan Statistics in medicine 33 (24), 4186-4201, 2014 | 114 | 2014 |
| Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom D Eleftheriou, G Varnier, P Dolezalova, AM McMahon, M Al-Obaidi, ... Arthritis research & therapy 17, 1-10, 2015 | 109 | 2015 |
| Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis C Papadopoulou, Y Hong, E Omoyinmi, PA Brogan, D Eleftheriou Brain 142 (3), e8-e8, 2019 | 85 | 2019 |
| Lifetime cardiovascular management of patients with previous Kawasaki disease P Brogan, JC Burns, J Cornish, V Diwakar, D Eleftheriou, JB Gordon, ... Heart 106 (6), 411-420, 2020 | 83 | 2020 |
| Developing and evaluating JIApp: acceptability and usability of a smartphone app system to improve self-management in young people with juvenile idiopathic arthritis RA Cai, D Beste, H Chaplin, S Varakliotis, L Suffield, F Josephs, D Sen, ... JMIR mHealth and uHealth 5 (8), e7229, 2017 | 83 | 2017 |
| Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function GI Rice, S Park, F Gavazzi, LA Adang, LA Ayuk, L Van Eyck, L Seabra, ... Human mutation 41 (4), 837-849, 2020 | 82 | 2020 |
| Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis E Omoyinmi, A Standing, A Keylock, F Price-Kuehne, S Melo Gomes, ... PloS one 12 (7), e0181874, 2017 | 81 | 2017 |
